Haemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapy

Thrombosis Journal

Table 3 Renal function following exercise.

Assay	Group	Baseline	Immediately post-exercise	1 hour post-exercise	P value
PCR	HV	7.0 (4.0–25.0)	9.0^† (5.0–34.0)	9 (5.0–31.0)	0.014
	IC	7.0 (2.0–52.0)	10.5^† (2.0–63.0)	7.5 (3.0–58.0)	0.005
ACR	HV	0.9 (0.9–13.2)	1.0 (0.9–19.6)	0.9 (0.9–20.2)	>0.05
	IC	1.0 (0.9–34.2)	1.75^‡ (0.9–34.7)	1.0 (0.9–31.3)	0.046
NAG	HV	0.7 (0.4–1.5)	0.8 (0.3–2.1)	0.8 (0.4–1.4)	>0.05
	IC	1.4 (0.2–7.8)	1.4 (0.2–6.8)	1.2 (0.2–5.0)	>0.05

HV = healthy volunteers, IC = patients with intermittent claudication. Numbers represent medians with the range in brackets. P values represent Friedman's test. ‡p < 0.05, †p < 0.001 (Wilcoxon signed rank test, comparisons made with baseline values).